Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 3Genitourinary 1

Conditions

Peritoneal Neoplasms 1Ovarian Cysts 1Hemorrhage 1Gynecologic Cancer 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
FloSeal Matrix × Clear all
NCT07232927 2025-11-18

HEMOSTA-PN

Ankara University

Phase NA Completed
150 enrolled
Genitourinary

Carcinoma, Renal Cell, Hemorrhage

NCT01957852 2015-02-25

FloSeal in CRS and HIPEC

Maisonneuve-Rosemont Hospital

Completed
86 enrolled
Gynecologic

Peritoneal Neoplasms

NCT01974193 2015-02-11

Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer

Ewha Womans University Mokdong Hospital

Phase 3 Unknown
40 enrolled
Gynecologic

Gynecologic Cancer

NCT01857466 2014-06-25

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

CHA University

Phase 3 Completed
100 enrolled
Gynecologic

Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡